Christopher Jewell

Nessuna posizione attualmente

Patrimonio netto: 790 773 $ in data 31/05/2026

45 anni

Consumer Services

Commercial Services

Profilo

Christopher Jewell worked as a Professor at the University of Maryland from 2020 to 2024.
Dr. Jewell served as Chief Scientific Officer at Cartesian Therapeutics, Inc. (United States) in 2023 and continued in the same role at Cartesian Therapeutics, Inc. from 2023 to 2025.
Dr. Jewell earned a doctorate from the University of Wisconsin.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valutazione	Data di valutazione
0,36%	14/04/2026	104.877 ( 0,36% )	790 773 $	31/05/2026

Precedenti posizioni note di Christopher Jewell

Società	Posizione	Fine
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/04/2024
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Direttore Tecnico/Scientifico/R&S	13/11/2023

Vedi nel dettaglio l'esperienza di Christopher Jewell

Formazione di Christopher Jewell

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Jewell

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Commercial Services